Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review

Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity reaction (HR) mediated by antigens to Aspergillus fumigatus. It is estimated that 2–15% of patients with cystic fibrosis (CF) and between 1% and 5% of asthmatics develop ABPA, affecting approximately 4.8 million people worldwide. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Eraso, Isabel C., Sangiovanni, Saveria, Morales, Eliana I., Fernández-Trujillo, Liliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576923/
https://www.ncbi.nlm.nih.gov/pubmed/33050821
http://dx.doi.org/10.1177/1753466620961648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576923/
https://www.ncbi.nlm.nih.gov/pubmed/33050821
http://dx.doi.org/10.1177/1753466620961648

Ejemplares similares